Human medicines European public assessment report (EPAR): Retsevmo, selpercatinib, Date of authorisation: 11/02/2021, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Adrovance, alendronic acid,colecalciferol, Date of authorisation: 04/01/2007, Revision: 29, Status: Authorised

PSUSA/00001516/202506

PSUSA/00010291/202506

PSUSA/00001499/202502

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 March 2026, 15:00 (CET) to 12 March 2026, 16:00 (CET)

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 25, Status: Authorised

CVMP recommendations on limited market classification and eligibility for authorisation under Article 23

Human medicines European public assessment report (EPAR): Trajenta, linagliptin, Date of authorisation: 23/08/2011, Revision: 23, Status: Authorised